Nodinitib-1,
ML130,
799264-47-4,
Noditinib-1,
ML130 (Nodinitib-1),
ML-130,
MLS001201458,
1-(4-methylphenyl)sulfonylbenzimidazol-2-amine,
1-(Toluene-4-sulfonyl)-1H-benzoimidazol-2-ylamine,
ML 130,
1-[(4-Methylphenyl)sulfonyl]-1H-benzimidazol-2-amine,
1-Tosyl-1H-benzo[d]imidazol-2-amine,
BAS 07162070,
SMR000523991,
Noditinib,
Nodithinib 1,
AC1LLPTT,
MLS002639479,
GTPL8887,
CHEMBL1412853,
SCHEMBL10107599,
(1-tosylbenzimidazol-2-yl)amine,
BDBM59542,
CHEBI:93561,
cid_1088438,
DTXSID10360187,
HMS2819O03,
HMS3651B21,
ZINC807071,
BCP20383,
Nodinitib-1, >=98% (HPLC),
2553AH,
CCG-25324,
MFCD04322367,
s2863,
AKOS000641831,
CS-6462,
MCULE-7249710756,
SB19544,
compound 1c [PMID: 22003428],
AK232161,
HY-18639,
FT-0673025,
SW219809-1,
1-(4-methylphenyl)sulfonyl-2-benzimidazolamine,
MLS-0350096.0001,
MLS-0350096.0002,
MLS-0350096.0003,
1-(4-methylbenzenesulfonyl)-1h-benzimidazol-2-amine,
1-[(4-Methylbenzene)sulfonyl]-1H-1,3-benzodiazol-2-amine,
Noditinibeta-1,
C14H13N3O2S,
ZINC00807071,
CID1088438,
B1646,